Hansard Global Plc (HSD)
London Stock Exchange · UK · prices in GBX · close of 27 Oct 2026
Key indicators
| Last close | GBX 56.50 |
|---|---|
| 52-week range | 43.20 – 60.80 |
| Return, 1 month / 3 months | +4.7% / +12.7% |
| Return, 1 year / 3 years | +37.4% / +61.3% |
| Trend | Uptrend |
| RSI (14) | 55 |
| Volatility (1 year) | 37.7% |
| Worst drawdown (1 year) | -14.0% |
| Average daily value traded | 3.80M GBX |
| Dividend yield | 7.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Hansard Global is a specialist provider of long-term savings and investment products, based in the Isle of Man. It designs regular premium savings plans and lump-sum investment products for international customers, including expatriates and higher-net-worth individuals. The company distributes its products through independent financial advisers and other intermediaries across a range of overseas markets rather than through its own branch network. Its business centres on helping policyholders build savings over time through unit-linked investment arrangements.
The shares are listed on the London Stock Exchange in UK under the code HSD, and the price on this page is in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Hansard Global Plc (HSD) trades on the London Stock Exchange in UK. It last closed at GBX 56.50 on 27 October 2026.
Its price-based Market X-Ray is 72 out of 100 (a strong price profile), ranking 397 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 37.4% and over the last three months it rose 12.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 78 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 14.0% | ||
| From 52-week high | -4.2% | ||
| Momentum | 79 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 12.7% | ||
| 6-month return | 16.9% | ||
| 12-month return, skipping the last month | 31.3% | ||
| Stability (higher is calmer) | 67 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 37.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -14.0% | ||
| Liquidity | 65 · Fair | Moderate trading activity. | |
| Average daily value traded | 3.80M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 66 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 7.9% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −0.4% |
|---|---|
| 1 month | +4.7% |
| 3 months | +12.7% |
| 6 months | +16.9% |
| 1 year | +37.4% |
| 3 years | +61.3% |
| 5 years | +74.9% |
Signals
| 50-day / 200-day average | 52.51 / 49.58 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.40 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 1 Oct 2026 | GBP 0.0265 |
| 12 Mar 2026 | GBP 0.0180 |
| 2 Oct 2025 | GBP 0.0265 |
| 13 Mar 2025 | GBP 0.0180 |
| 3 Oct 2024 | GBP 0.0265 |
| 14 Mar 2024 | GBP 0.0180 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.